EMMA Chart
- 52-Week Range: $1.10 - $2.15
- Market Capitalization: $66.57M
- Short Percentage: 0%
- Target Price: $5.70
- Shares Outstanding: 49.31M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Emmaus Life Sciences says successfully expands market access to sickle cell treatment Endari in 1QProactive Investors | May 13th
- Emmaus Life Sciences presents positive study data on Endari treatment in sickle cell patientsProactive Investors | April 7th
- Emmaus Life Sciences says it is making progress in expanding access to Endari as it reports FY2021 revenue of $20.6MProactive Investors | April 1st
- Emmaus Life Sciences Reports 2021 Financial Results and Provides Business UpdatePRNewsWire | March 31st
- Emmaus Life Sciences wins marketing authorization for Endari in United Arab EmiratesProactive Investors | March 23rd
- Emmaus Life Sciences is tackling debilitating sickle cell disease as it eyes other remediesProactive Investors | January 11th
- Emmaus Life Sciences to Present at the H.C. Wainwright BioConnect ConferencePRNewsWire | January 4th
- Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum on December 16thPRNewsWire | December 9th
Company Info
Website: https://www.emmausmedical.com
Address: 21250 Hawthorne Boulevard, Torrance, CA, United States, 90503
Sector: Healthcare
Industry: Biotechnology
Full time employees: 58
Address: 21250 Hawthorne Boulevard, Torrance, CA, United States, 90503
Sector: Healthcare
Industry: Biotechnology
Full time employees: 58
$EMMA Awaiting buy signal..
$EMMA f this stock
$EMMA Dumping started...
Get out while you can...
$EMMA Here we go!!!
$EMMA Moon soon
$EMMA when's the offering?
$EMMA buy the dip were blasting off
$EMMA who else finds themselves here after liquidating their positions for a loss only to bash on how seriously fcked up the stock market is
$EMMA I like the stock!